Delivery Order SPE2DB22D1017-SPE2DB24FF1FF
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Firm Fixed Price Delivery Order worth $76,466.38 awarded by the Defense Logistics Agency (DLA). The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, and has an ultimate completion date of March 1, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30s. The award, valued at $40,281.54, is a firm fixed-price delivery order contract issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of November 20, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award, valued at $77,205.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the medical product BIKTARVY 50-200-25 MG TABLET UU 30S. The award has an ultimate completion date of February 15, 2024, and a pricing type of Firm Fixed Price. Amerisourcebergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $7,525.83 for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of May 1, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $54,991.16 for the supply of BIKTARVY 50-200-25 MG TABLET. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 11, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $21,494.92 for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award, valued at $83,775.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET medical products, with an ultimate completion date of August 2, 2021. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,603.48 firm fixed-price delivery order is for the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S. The award has an ultimate completion date of January 4, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. The $13,427.06 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $110,308.08 firm fixed-price delivery order has a completion date of May 4, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF1FFDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a fixed price of $20,689.08 and a period of performance through January 16, 2024. It is a delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal government agencies, particularly supporting military and veterans' healthcare programs. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, as well as a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024. These IDCs enable the efficient procurement of essential pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.7k | 1/12/24 |